Old Web
English
Sign In
Acemap
>
Paper
>
Is it time for everolimus-based combination in castration-resistant prostate cancer?
Is it time for everolimus-based combination in castration-resistant prostate cancer?
2016
Giandomenico Roviello
Andrea Ravelli
Sandro Barni
Fausto Petrelli
Alberto Bottini
Stephen B. Fox
Daniele Generali
Keywords:
Immunology
Prostate cancer
Castration
PI3K/AKT/mTOR pathway
Oncology
Cancer research
Everolimus
Internal medicine
Medicine
castration resistant
Correction
Source
Cite
Save
Machine Reading By IdeaReader
19
References
1
Citations
NaN
KQI
[]